General AML

Prof. Richard Stone | EBMT 2018 | What are the latest advances in monitoring MRD in AML?

L:

At the 44th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting, 18–21 Mar 2018, Lisbon, PT,  Prof. Richard Stone from the Dana-Farber Cancer Institute, Boston, US, discusses the different methods of detecting MRD in acute myeloid leukemia (AML) including multiparameter flow cytometry (MFC) and real-time quantitative polymerase chain reaction (RQ-PCR) and also the use of the data obtained from these analysis.